Pacira BioSciences (PCRX)
36.34
0.00 (0.00%)
Upcoming Events
Latest Headlines
PharmaCorp to Present as Planet Microcap Toronto 2026 Conference
October 21, 2026 11:36 AM - Globe NewsWire
PharmaCorp names Andrew Hodson as CFO, replacing retiring Terri Tatchell
October 14, 2026 7:30 AM - StreetInsider
PharmaCorp Announces CFO Transition and Appointment of Andrew Hodson as Chief Financial Officer
October 14, 2026 7:30 AM - Globe NewsWire
Form SCHEDULE 13D/A Pacira BioSciences, Inc. Filed by: Doma Perpetual Capital Management LLC
October 13, 2026 5:55 PM - SEC Filing
Form 4 Pacira BioSciences, Inc. For: Oct 08 Filed by: RIKER LAUREN
October 9, 2026 7:08 PM - SEC Filing
H.C. Wainwright Downgrades Pacira Pharmaceuticals (PCRX) to Neutral
October 9, 2026 6:14 AM - StreetInsider
Form SC TO-C Pacira BioSciences, Inc. Filed by: Viatris Inc
October 8, 2026 4:46 PM - SEC Filing
Form SC14D9C Pacira BioSciences, Inc. Filed by: Pacira BioSciences, Inc.
October 8, 2026 4:15 PM - SEC Filing
Pacira Pharmaceuticals (PCRX) PT Raised to $36.50 at RBC Capital
October 8, 2026 2:09 PM - StreetInsider
Oppenheimer Downgrades Pacira Pharmaceuticals (PCRX) to Perform
October 8, 2026 1:26 PM - StreetInsider
Jefferies Downgrades Pacira Pharmaceuticals (PCRX) to Hold
October 8, 2026 12:37 PM - StreetInsider
Needham Downgrades Pacira Pharmaceuticals (PCRX) to Hold
October 8, 2026 12:18 PM - StreetInsider
JPMorgan Upgrades Pacira Pharmaceuticals (PCRX) to Neutral
October 8, 2026 12:18 PM - StreetInsider
Form 144 Pacira BioSciences, Inc. Filed by: RIKER LAUREN
October 8, 2026 10:02 AM - SEC Filing
Form 8-K Pacira BioSciences, Inc. For: Oct 08
October 8, 2026 9:25 AM - SEC Filing
Form SC TO-C Pacira BioSciences, Inc. Filed by: Viatris Inc
October 8, 2026 8:46 AM - SEC Filing
Viatris to acquire Pacira BioSciences for $1.65 billion
October 8, 2026 7:45 AM - StreetInsider
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
October 8, 2026 7:45 AM - PR NewsWire
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
October 7, 2026 8:00 AM - StreetInsider
Pacira Pharmaceuticals (PCRX) PT Raised to $31 at Truist Securities
October 7, 2026 7:14 AM - StreetInsider
Pacira strikes EU deal with Molteni to sell EXPAREL painkiller
October 5, 2026 8:05 AM - StreetInsider
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
October 5, 2026 8:00 AM - StreetInsider
PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update
October 1, 2026 5:00 PM - Globe NewsWire
Oppenheimer Starts Pacira Pharmaceuticals (PCRX) at Outperform
September 23, 2026 6:08 AM - StreetInsider
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 9, 2026 8:00 AM - StreetInsider
Leerink Starts Pacira Pharmaceuticals (PCRX) at Market Perform
September 9, 2026 6:10 AM - StreetInsider
PharmaCorp Rx Inc. Announces Board and Committee Changes
August 27, 2026 7:30 AM - Globe NewsWire
PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results
August 20, 2026 7:30 AM - Globe NewsWire
Form 4 Pacira BioSciences, Inc. For: Aug 17 Filed by: SLONIN JONATHAN
August 18, 2026 5:21 PM - SEC Filing
Form 144 Pacira BioSciences, Inc. Filed by: SLONIN JONATHAN
August 17, 2026 11:54 AM - SEC Filing
Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
August 17, 2026 6:14 AM - StreetInsider
Form SCHEDULE 13G Pacira BioSciences, Inc. Filed by: STATE STREET CORP
August 7, 2026 10:33 AM - SEC Filing
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 8:00 AM - StreetInsider
Pacira publishes two-year Phase 1 data for knee OA gene therapy
August 6, 2026 8:00 AM - StreetInsider
Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
August 6, 2026 8:00 AM - StreetInsider
Pacira Pharmaceuticals (PCRX) PT Raised to $25 at RBC Capital
August 5, 2026 7:49 AM - StreetInsider
Pacira Pharma (PCRX) Tops Q2 EPS by 8c ; Offers Guidance
August 5, 2026 12:41 AM - StreetInsider
Form S-8 Pacira BioSciences, Inc.
August 4, 2026 5:11 PM - SEC Filing
Form 10-Q Pacira BioSciences, Inc. For: Jun 30
August 4, 2026 4:32 PM - SEC Filing
Form 8-K Pacira BioSciences, Inc. For: Aug 04
August 4, 2026 4:04 PM - SEC Filing
Pacira BioSciences Reports Second Quarter 2026 Financial Results
August 4, 2026 4:01 PM - StreetInsider
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
July 28, 2026 8:00 AM - StreetInsider
Pacira enrolls first patient in PCRX-201 Phase 2 study Part B
July 27, 2026 8:04 AM - StreetInsider
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
July 27, 2026 8:00 AM - StreetInsider
Full Article List
